Chronic myeloid leukemia in the Asia-Pacific region: Current practice, challenges and opportunities in the targeted therapy era-Reference-Cited by-同舟云学术

Chronic myeloid leukemia in the Asia-Pacific region: Current practice, challenges and opportunities in the targeted therapy era

Published:2010-11 Issue:11 Volume:34 Page:1459-1471
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Kim Dong-Wook,Banavali Shripad D.,Bunworasate Udomsak,Goh Yeow-Tee,Ganly Peter,Huang He,Irving Ian,Jootar Saengsuree,Goh Hyun-Gyung,Koh Liang-Piu,Li Wei,Naoe Tomoki,Ng Soo-Chin,Purushotaman Visalachy,Reksodiputro Harryanto,Shih Lee-Yung,Tang Jih-Luh,Tojo Arinobu,Wang Jianmin,Wong Raymond

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference23 articles.

1. Chronic myeloid leukemia in Asia;Wing;Int J Hematol,2009

2. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia;O’Brien;N Engl J Med,2003

3. Guilhot F, Larson R, O’Brien S, Druker B, on behalf of IRIS Study Group. Long-term benefits of imatinib for patients newly diagnosed with chronic myeloid leukemia in chronic phase: the 5-year update from the IRIS study. Haematologica 2006;91:170 [Abstract 466].

4. Recommendations of the Canadian consensus group on the management of chronic myeloid leukemia;Laneuville;Curr Oncol,2006

5. Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet;Baccarani;Blood,2006

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Asia‐Pacific Leukemia Consortium: An innovative and collaborative initiative to improve care of leukemia and related diseases in the Asia‐Pacific region;Asia-Pacific Journal of Clinical Oncology;2023-06

2. Classic myeloproliferative neoplasms in Singapore: A population-based study on incidence, trends, and survival from 1968 to 2017;Cancer Epidemiology;2022-08

3. Comparison of Dasatinib- and Imatinib-Related Cardiotoxic Adverse Events in Japanese Patients With Chronic Myeloid Leukemia and Gastrointestinal Stromal Tumor;Circulation Reports;2022-01-07

4. Potential to Improve Therapy of Chronic Myeloid Leukemia (CML), Especially for Patients with Older Age: Incidence, Mortality, and Survival Rates of Patients with CML in Switzerland from 1995 to 2017;Cancers;2021-12-14